journal article·2020-08

Potential applications of multifunctional mesoporous carbon nanoplatform for tumor microenvironment improving by combined chemo-/phototherapy

Ying Zhang, Jingyao Zhu, Gang Huang, Jun Zhu, Dannong He

Carbon· Volume 163
Publisher page

Abstract

Abstract At present, conventional drug therapy for tumor strongly stimulates tumor tissue, leading to tumor necrosis and acute inflammatory response, and tumor metastasis. How to kill tumor cells under mild conditions and prolong the survival of patients is a hot topic of tumor therapy. In this study, a multifunctional nanoplatform was designed based on mesoporous carbon nanoparticles, grafting with anti-inflammatory drug (celecoxib) and loading chemotherapy drug (doxorubicin). The constructed nanoplatform mesoporous carbon/celecoxib @doxorubicin was found to capable of, induce intravascular thrombosis, blocking nutrient supply for tumor, and over-inflammatory suppression avoiding acute tissue necrosis. Meanwhile, this study demonstrates combined chemo- and photothermal therapy and exhibits a promising potential in cancer therapy.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Inflammatory Biomarkers in Disease Prognosis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (37)

Show source-provided references
1. Cell membrane coating for reducing nanoparticle-induced inflammatory responses to scaffold constructs10.1007/s12274-018-2084-y ↗
2. Cancer-related inflammation10.1038/nature07205 ↗
3. Immune cell types and secreted factors contributing to inflammation-to-cancer transition and immune therapy response10.1016/j.celrep.2019.01.080 ↗
4. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression10.1158/0008-5472.CAN-07-2354 ↗
5. Macrophage diversity enhances tumor progression and metastasis10.1016/j.cell.2010.03.014 ↗
6. Inflammation fires up cancer metastasis10.1016/j.semcancer.2017.08.006 ↗
7. Immunity, inflammation, and cancer10.1016/j.cell.2010.01.025 ↗
8. Microbiome, inflammation and colorectal cancer10.1016/j.smim.2017.09.006 ↗
9. Trifluoromethyl fluorocoxib a detects cyclooxygenase-2 expression in inflammatory tissues and human tumor xenografts10.1021/ml400485g ↗
10. Inflammation and colon cancer10.1053/j.gastro.2010.01.058 ↗
11. Colon cancer: inflammation-associated cancer10.1016/j.soc.2017.11.003 ↗
12. Inflammation and cancer10.1038/nature01322 ↗
13. Chapter 6 - PIK3CA mutations in colorectal and breast cancer: impact on oncogenesis and response to nonsteroidal anti-inflammatory drugs
14. Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention10.1053/j.seminoncol.2015.09.010 ↗
15. ≤Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2.Pdf>.
16. Prostaglandins and chronic inflammation10.1016/j.tips.2012.02.004 ↗
17. Programmed multiresponsive vesicles for enhanced tumor penetration and combination therapy of triple-negative breast cancer10.1002/adfm.201606530 ↗
18. Pro-inflammatory prostaglandins and progression of colorectal cancer10.1016/j.canlet.2008.03.004 ↗
19. Ordered mesoporous materials for drug delivery
20. A low-concentration hydrothermal synthesis of biocompatible ordered mesoporous carbon nanospheres with tunable and uniform size10.1002/anie.201002849 ↗
21. Thermo-sensitively and magnetically ordered mesoporous carbon nanospheres for targeted controlled drug release and hyperthermia application10.1016/j.msec.2017.11.033 ↗
22. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy10.1016/j.actbio.2018.12.028 ↗
23. Advances in transformable drug delivery systems10.1016/j.biomaterials.2018.03.056 ↗
24. Porous hollow palladium nanoplatform for imaging-guided trimodal chemo-, photothermal-, and radiotherapy10.1007/s12274-017-1910-y ↗
25. Mesoporous systems for poorly soluble drugs – recent trends10.1016/j.ijpharm.2017.11.054 ↗
26. Ordered mesoporous carbons for ibuprofen drug loading and release behavior10.1016/j.micromeso.2010.12.018 ↗
27. Hollow mesoporous carbon as a near-infrared absorbing carrier compared with mesoporous carbon nanoparticles for chemo-photothermal therapy10.1016/j.jcis.2017.01.090 ↗
28. Templated mesoporous carbons: synthesis and applications10.1016/j.carbon.2016.06.003 ↗
29. Multifunctional nanoparticle systems for combined chemoand photothermal cancer therapy10.1007/s11706-013-0207-7 ↗
30. A versatile theranostic nanoplatform based on mesoporous silica10.1016/j.msec.2019.01.004 ↗
31. Nanoscale covalent organic framework for combinatorial antitumor photodynamic and photothermal therapy10.1021/acsnano.9b06467 ↗
32. A chemophotothermal and targeting multifunctional nanoprobe with a tumor-diagnosing ability10.1007/s12274-018-2021-0 ↗
33. A chemo/photo- co-therapeutic system for enhanced multidrug resistant cancer treatment using multifunctional mesoporous carbon nanoparticles coated with poly (curcumin-dithiodipropionic acid)10.1016/j.carbon.2017.07.008 ↗
34. Efficacy of a novel LyP-1-containing self-microemulsifying drug delivery system (SMEDDS) for active targeting to breast cancer10.1016/j.ejpb.2019.01.017 ↗
35. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo10.1038/nbt.4071 ↗
36. Construction of DOX/APC co-loaded BiOI@CuS NPs for safe and highly effective CT imaging and chemo-photothermal therapy of lung cancer10.1039/C9TB01874C ↗
37. Development of dual–release pellets of the non-steroidal anti–inflammatory drug celecoxib